Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For CACC
Valuation Bad
0%
Profitability n.A.
Fin. Growth Weak
17%
Leverage & Liquidity Weak
33%
Per Share Metrics Best
100%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 3.40 19.24 18.60
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -68.77 13.56 43.42
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value -3.56 132.38 137.27
Cash 450.57 45.85 8.33
Capex 81.94 -0.02 -0.13
Free Cash Flow 2.43 24.81 24.23
Revenue 5.77 40.70 38.48
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 46.84 0.99 0.67
Operating Margin 203.37 0.72 0.24
ROA -35.43 < 0.005 0.01
ROE -27.08 0.04 0.05
ROIC 175.42 0.04 0.01
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of CACC is permitted for members.
5 Growth
The "Growth Entry" for the Focus of CACC is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of CACC is permitted for members.